Sfoglia per AUTORE
TAULLI R
Collezione AOU San Luigi di Orbassano

  

Items : 13

From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment. in International journal of molecular sciences / Int J Mol Sci. 2024 Oct 9;25(19):10823. doi: 10.3390/ijms251910823.
2024
AOU San Luigi di Orbassano

Picca F; Giannotta C; Tao J; Giordanengo L; Munir HMW; Botta V; Merlini A; Mogavero A; Garbo E; Poletto S; Bironzo P; Doronzo G; Novello S; Taulli R; Bersani F;

Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2023 May 12;42(1):120. doi: 10.1186/s13046-023-02690-5.
2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Bardelli A; Di Nicolantonio F; Pietrantonio F; Poli V; Monteleone E; Bironzo P; Tabbò F; Benso F; Zambelli V; Listì A; Volante M; Castella B; Rospo G; Negrino C; Oddo D; Russo M; Napoli F; Righi L; Morena D; Picca F; Bersani F; Ponzetto C; Novello S; Scagliotti GV; Taulli R;

Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2023 Feb 1;29(3):621-634. doi: 10.1158/1078-0432.CCR-22-0761.
2023
AOU San Luigi di Orbassano

Rotolo R; Leuci V; Donini C; Galvagno F; Massa A; De Santis MC; Peirone S; Medico G; Sanlorenzo M; Vujic I; Gammaitoni L; Basiricò M; Righi L; Riganti C; Salaroglio IC; Napoli F; Tabbò F; Mariniello A; Vigna E; Modica C; D'Ambrosio L; Grignani G; Taulli R; Hirsch E; Cereda M; Aglietta M; Scagliotti GV; Novello S; Bironzo P; et alii...

Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Apr;184:103966. doi: 10.1016/j.critrevonc.2023.103966. Epub 2023 Mar 15
2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Scagliotti GV; Taulli R; Yoshizumi T; Novello S; Seto T; Haratake N; Takenaka T; Tabbò F; Picca F; Bersani F; Bironzo P; Toyokawa G;

SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2022 Feb 23;41(1):75. doi: 10.1186/s13046-022-02284-7.
2022
AOU San Luigi di Orbassano

Salaroglio IC; Belisario DC; Bironzo P; Ananthanarayanan P; Ricci L; Digiovanni S; Fontana S; Napoli F; Sandri A; Facolmatà C; Libener R; Comunanza V; Grosso F; Gazzano E; Leo F; Taulli R; Bussolino F; Righi L; Papotti MG; Novello S; Scagliotti GV; Riganti C; Kopecka J;

Correction to: Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2022 Aug;481(2):331. doi: 10.1007/s00428-022-03355-y.
2022
AOU San Luigi di Orbassano

Napoli F; Rapa I; Izzo S; Rigutto A; Libener R; Riganti C; Bironzo P; Taulli R; Papotti M; Volante M; Scagliotti G; Righi L;

Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2022 Aug;481(2):233-244. doi: 10.1007/s00428-022-03321-8. Epub 2022 Apr 24.
2022
AOU San Luigi di Orbassano

Napoli F; Rapa I; Izzo S; Rigutto A; Libener R; Riganti C; Bironzo P; Taulli R; Papotti M; Volante M; Scagliotti G; Righi L;

Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma. in Cancers / Cancers (Basel). 2021 May 12;13(10):2332. doi: 10.3390/cancers13102332.
2021
AOU Alessandria
AOU San Luigi di Orbassano

Aviles P; Libener R; Leo F; Guerrera F; Sandri A; Comunanza V; Gigliotti C; Bussolino F; Di Nicolantonio F; Pittaro A; Papotti MG; Napoli F; Righi L; Morena D; Lingua MF; Picca F; Bironzo P; Anobile DP; Novello S; Taulli R; Scagliotti GV; Riganti C;

Future perspectives from lung cancer pre-clinical models: new treatments are coming? in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2629-2644. doi: 10.21037/tlcr-20-189.
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Righi L; Bironzo P; Tabbò F; Morotti A; Picca F; Morena D; Bersani F; Taulli R;

NIBIT-MESO-1: limitations and clinical perspectives in MPM treatment testing an immune checkpoint blockade combination in a single-arm study. in Journal of thoracic disease / J Thorac Dis. 2018 Nov;10(Suppl 33):S3878-S3881. doi: 10.21037/jtd.2018.09.135.
2018
AOU San Luigi di Orbassano

Bironzo P; Taulli R;

Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. in Oncoimmunology / Oncoimmunology. 2017 Nov 27;7(3):e1398874. doi: 10.1080/2162402X.2017.1398874. eCollection 2018.
2018
AOU San Luigi di Orbassano

Riganti C; Lingua MF; Salaroglio IC; Falcomatà C; Righi L; Morena D; Picca F; Oddo D; Kopecka J; Pradotto M; Libener R; Orecchia S; Bironzo P; Comunanza V; Bussolino F; Novello S; Scagliotti GV; Di Nicolantonio F; Taulli R; Riganti C; Lingua MF; Salaroglio IC; Falcomatà C; Righi L; Morena D; Picca F; Oddo D; Kopecka J; Pradotto M; et alii...

Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones. in Oncotarget / Oncotarget. 2017 May 30;8(22):35508-35522. doi: 10.18632/oncotarget.16348.
2017
AOU San Luigi di Orbassano

Carrà G; Panuzzo C; Torti D; Parvis G; Crivellaro S; Familiari U; Volante M; Morena D; Lingua MF; Brancaccio M; Guerrasio A; Pandolfi PP; Saglio G; Taulli R; Morotti A;

2016
AOU San Luigi di Orbassano

Crivellaro S; Carrà G; Panuzzo C; Taulli R; Guerrasio A; Saglio G; Morotti A;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte